Biogen Rises 6.2% After Strong Study Results
January 08, 2015 at 07:56 AM EST
Biogen Idec's stock was up 6.2% after the company reported Thursday that a treatment for acute optic neuritis it has developed proved to be effective in the second phase of a research study.